MeSH tree: D12.776.124.790.651.114.580
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...
Nov 17, 2025
0
49
Australian researchers have discovered that an anti-inflammatory drug already being used to treat rheumatoid arthritis could dramatically improve recovery from heart attacks. The work is published in the journal Cardiovascular ...
Oct 8, 2025
0
52
University of Oklahoma researchers have discovered that some bacteria in the gut have their own unique "weapon system" to compete against other bacteria for dominance. Importantly, there is promising evidence that this system ...
May 15, 2025
0
46
Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.
Nov 6, 2024
0
22
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.
Oct 23, 2024
0
20
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
May 22, 2024
0
52
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
Mar 4, 2024
0
67
A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. Results from a Phase 2b clinical trial, published today in The Lancet by researchers led by King's College London, ...
Feb 13, 2024
0
144
Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared ...
Jul 10, 2023
0
41
Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive therapy. A small open-label ...
Mar 8, 2023
0
63
